173 related articles for article (PubMed ID: 19103167)
1. 3D cultured immortalized human hepatocytes useful to develop drugs for blood-borne HCV.
Aly HH; Shimotohno K; Hijikata M
Biochem Biophys Res Commun; 2009 Feb; 379(2):330-4. PubMed ID: 19103167
[TBL] [Abstract][Full Text] [Related]
2. Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes.
Aly HH; Watashi K; Hijikata M; Kaneko H; Takada Y; Egawa H; Uemoto S; Shimotohno K
J Hepatol; 2007 Jan; 46(1):26-36. PubMed ID: 17112629
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K
Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor alpha antagonism inhibits hepatitis C virus replication.
Rakic B; Sagan SM; Noestheden M; Bélanger S; Nan X; Evans CL; Xie XS; Pezacki JP
Chem Biol; 2006 Jan; 13(1):23-30. PubMed ID: 16426968
[TBL] [Abstract][Full Text] [Related]
5. Direct imaging of the disruption of hepatitis C virus replication complexes by inhibitors of lipid metabolism.
Lyn RK; Kennedy DC; Sagan SM; Blais DR; Rouleau Y; Pegoraro AF; Xie XS; Stolow A; Pezacki JP
Virology; 2009 Nov; 394(1):130-42. PubMed ID: 19747705
[TBL] [Abstract][Full Text] [Related]
6. Evaluation systems for anti-HCV drugs.
Moriishi K; Matsuura Y
Adv Drug Deliv Rev; 2007 Oct; 59(12):1213-21. PubMed ID: 17720275
[TBL] [Abstract][Full Text] [Related]
7. Morphine inhibits intrahepatic interferon- alpha expression and enhances complete hepatitis C virus replication.
Li Y; Ye L; Peng JS; Wang CQ; Luo GX; Zhang T; Wan Q; Ho WZ
J Infect Dis; 2007 Sep; 196(5):719-30. PubMed ID: 17674315
[TBL] [Abstract][Full Text] [Related]
8. Thromboxane A2 synthase inhibitors prevent production of infectious hepatitis C virus in mice with humanized livers.
Abe Y; Aly HH; Hiraga N; Imamura M; Wakita T; Shimotohno K; Chayama K; Hijikata M
Gastroenterology; 2013 Sep; 145(3):658-67.e11. PubMed ID: 23684750
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
10. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T
Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316
[TBL] [Abstract][Full Text] [Related]
11. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
[TBL] [Abstract][Full Text] [Related]
12. HCV research and anti-HCV drug discovery: toward the next generation.
Wakita T
Adv Drug Deliv Rev; 2007 Oct; 59(12):1196-9. PubMed ID: 17905463
[TBL] [Abstract][Full Text] [Related]
13. Cellular models for the screening and development of anti-hepatitis C virus agents.
Gondeau C; Pichard-Garcia L; Maurel P
Pharmacol Ther; 2009 Oct; 124(1):1-22. PubMed ID: 19555718
[TBL] [Abstract][Full Text] [Related]
14. Development of a simple system for screening anti-hepatitis C virus drugs utilizing mutants capable of vigorous replication.
Yu L; Aoki C; Shimizu Y; Shimizu K; Hou W; Yagyu F; Wen X; Oshima M; Iwamoto A; Gao B; Liu W; Gao GF; Kitamura Y
J Virol Methods; 2010 Nov; 169(2):380-4. PubMed ID: 20713089
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus complete life cycle screen for identification of small molecules with pro- or antiviral activity.
Gentzsch J; Hinkelmann B; Kaderali L; Irschik H; Jansen R; Sasse F; Frank R; Pietschmann T
Antiviral Res; 2011 Feb; 89(2):136-48. PubMed ID: 21167208
[TBL] [Abstract][Full Text] [Related]
16. Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes.
Podevin P; Carpentier A; Pène V; Aoudjehane L; Carrière M; Zaïdi S; Hernandez C; Calle V; Méritet JF; Scatton O; Dreux M; Cosset FL; Wakita T; Bartenschlager R; Demignot S; Conti F; Rosenberg AR; Calmus Y
Gastroenterology; 2010 Oct; 139(4):1355-64. PubMed ID: 20600021
[TBL] [Abstract][Full Text] [Related]
17. High-throughput screening of HCV RNA replication inhibitors by means of a reporter replicon system.
Hao W; Duggal R
Methods Mol Biol; 2009; 510():243-50. PubMed ID: 19009266
[TBL] [Abstract][Full Text] [Related]
18. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes.
Ikeda M; Sugiyama K; Tanaka T; Tanaka K; Sekihara H; Shimotohno K; Kato N
Biochem Biophys Res Commun; 1998 Apr; 245(2):549-53. PubMed ID: 9571193
[TBL] [Abstract][Full Text] [Related]
19. Phosphoramidate prodrugs of 2'-C-methylcytidine for therapy of hepatitis C virus infection.
Gardelli C; Attenni B; Donghi M; Meppen M; Pacini B; Harper S; Di Marco A; Fiore F; Giuliano C; Pucci V; Laufer R; Gennari N; Marcucci I; Leone JF; Olsen DB; MacCoss M; Rowley M; Narjes F
J Med Chem; 2009 Sep; 52(17):5394-407. PubMed ID: 19725579
[TBL] [Abstract][Full Text] [Related]
20. Novel robust hepatitis C virus mouse efficacy model.
Zhu Q; Oei Y; Mendel DB; Garrett EN; Patawaran MB; Hollenbach PW; Aukerman SL; Weiner AJ
Antimicrob Agents Chemother; 2006 Oct; 50(10):3260-8. PubMed ID: 17005803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
